Abstract
Glioblastoma 3 (Gli3) is a transcription factor involved in patterning and oncogenesis. Here, we demonstrate a role for Gli3 in thymocyte development. Gli3 is differentially expressed in fetal CD4-CD8- double-negative (DN) thymocytes and is most highly expressed at the CD44 + CD25- DN (DN1) and CD44-CD25- (DN4) stages of development but was not detected in adult thymocytes. Analysis of null mutants showed that Gli3 is involved at the transitions from DN1 to CD44+ CD25+ DN (DN2) cell and from DN to CD4+CD8+ double-positive (DP) cell. Gli3 is required for differentiation from DN to DP thymocyte, after pre-T-cell receptor (TCR) signaling but is not necessary for pre-TCR-induced proliferation or survival. The effect of Gli3 was dose dependent, suggesting its direct involvement in the transcriptional regulation of genes controlling T-cell differentiation during fetal development. © 2005 by The American Society of Hematology.
Cite
CITATION STYLE
Hager-Theodorides, A. L., Dessens, J. T., Outram, S. V., & Crompton, T. (2005). The transcription factor Gli3 regulates differentiation of fetal CD4 -CD8- double-negative thymocytes. Blood, 106(4), 1296–1304. https://doi.org/10.1182/blood-2005-03-0998
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.